The achievement is a part of JB’s ongoing ‘One Mission, Nephro Protection’ campaign
JB Pharma has been recognised by the Asia Book of Records for conducting a remarkable 17,202 microalbuminuria tests within a single week. This achievement is a part of JB’s ongoing ‘One Mission, Nephro Protection’ campaign, focused on raising awareness about the early detection of kidney damage in hypertensive patients.
“Achieving this recognition from the Asia Book of Records for conducting the highest number of microalbuminuria tests in such a short period is a testament to our long-standing commitment to advancing optimum therapeutic outcomes for hypertensive patients in India,” stated Dilip Singh Rathore, President, India Business, JB Pharma. “Having conducted more than 5 lakh screenings over the past eight years, this recent accomplishment demonstrates our intensified focus on proactive hypertension management and kidney protection.”
Vikas Khare, Executive Vice President – Chronic Cluster, India Business, JB Pharma explained, “Microalbuminuria testing is vital for identifying early signs of kidney stress in hypertensive patients, often before chronic kidney disease develops. Since hypertension can severely affect kidney health, detecting microalbuminuria early allows for timely action to protect kidney function and improve patient outcomes. With this record achievement, we, at JB Pharma continue to advance on our promise of being Good People for Good Health.”
